Key points are not available for this paper at this time.
The aim of the study is to develop an environmentally friendly development of isolating silver nanoparticles using Argyreia nervosa plant leaves and examine their potential pharmacological properties, including antibacterial, anti-inflammatory, antioxidant, and anti-diabetic activities. Various analytical techniques were employed to examine the isolated silver nanoparticles, encompassing UV spectroscopy, XRD, SEM, EDX, FTIR, zeta potential measurement, and particle size determination. Furthermore, Argyreia nervosa-mediated silver nanoparticles exhibited strong antioxidant, anti-inflammatory activity, and good anti-diabetic activity. Argyreia nervosa-mediated nanoparticles showed a significant antibacterial activity against selected pathogens. The findings indicate that Argyreia nervosa demonstrates encouraging pharmacological properties. However, additional in vivo research focusing on molecular-level investigations is necessary to substantiate these findings and explore the potential of Argyreia nervosa-mediated silver nanoparticles as a viable drug for antioxidant, antibacterial, and anti-diabetic purposes.
Krishnamoorthy et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: